Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-19

Clinical Trial Update: The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial [Phase 1]

View source ↗

Summary

A randomized, double-blind Phase 1 trial comparing 1% topical papaya leaf extract ointment with 2% mupirocin ointment for the treatment of limited impetigo, eva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mupirocin 2% Ointment (mupirocin)
  • Topical Papaya Leaf Extract 1% Ointment (papaya leaf extract)

Snippet

Sponsor: Philippine Dermatological Society | Conditions: Impetigo | Phase 1 | Status: UNKNOWN